Recent Updates
Recently added Catalysts
RAPP

Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member

Key Takeaway: Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+91%
120-day peak, hindsight
Typical move
10.7%
average across 6 past catalysts
Cash runway
~31 mo
Minimal dilution risk
Lead asset
RAP-219
Phase 3 · Focal Seizure

Full Press Release Details

Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member.
Last updated: Sep 7, 2023